T 2345/17 (HRT Formulations / NOVO NORDISK) of 25.09.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T234517.20230925
- Date of decision
- 25 September 2023
- Case number
- T 2345/17
- Petition for review of
- -
- Application number
- 04762858.1
- IPC class
- A61K 31/57A61K 31/56A61K 9/20
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- HRT FORMULATIONS
- Applicant name
- Novo Nordisk Health Care AG
- Opponent name
- Actavis Group PTC ehf
Generics [UK] Ltd (trading as Mylan) - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- All requests - inventive step - (no)
- Catchword
- -
- Cited cases
- T 1323/17
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.